Jan-Shiang Taur

Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria

M. Jamei, X. Chu, K. Hillgren, 2013, Drug Metabolism and Disposition.

Interactions between the chemotherapeutic agent eribulin mesylate (E7389) and P-glycoprotein in CF-1 abcb1a-deficient mice and Caco-2 cells

Y. Wong, E. Schuck, Jan-Shiang Taur, 2011, Xenobiotica; the fate of foreign compounds in biological systems.

Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models

Jan-Shiang Taur, R. Rodriguez-Proteau, 2008, Xenobiotica; the fate of foreign compounds in biological systems.

A transcellular assay to assess the P-gp inhibition in early stage of drug development.

E. Schuck, Jan-Shiang Taur, N. Wong, 2013, Drug metabolism letters.

Application of Receiver Operating Characteristic Analysis to Refine the Prediction of Potential Digoxin Drug Interactions

Sophie P. Chung, Shibing Deng, M. Jamei, 2013, Drug Metabolism and Disposition.

DMD050542 1367..1374

Sophie P. Chung, Shibing Deng, M. Jamei, 2013 .

The Prevalence of Several Treatments in Preventing the Back Conversion of Acyl Glucuronide Metabolites in Abbreviated New Drug Applications

M. Darna, Jan-Shiang Taur, Jinzhe Mao, 2023, The AAPS Journal.

Interactions between the chemotherapeutic agent eribulin mesylate (E7389) and P-glycoprotein in CF-1 abcb1a-deficient mice and Caco-2 cells

E. Schuck, Jan-Shiang Taur, C. Desjardins, 2011, Xenobiotica; the fate of foreign compounds in biological systems.